X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (15) 15
hematology (14) 14
humans (14) 14
health aspects (9) 9
chemotherapy (7) 7
liposomal amphotericin-b (7) 7
antifungal agents - therapeutic use (6) 6
care and treatment (6) 6
medicine & public health (6) 6
mycoses (6) 6
oncology (6) 6
acute myeloid-leukemia (5) 5
amphotericin b (5) 5
cancer (5) 5
infectious diseases (5) 5
leukemia (5) 5
middle aged (5) 5
mortality (5) 5
transplantation (5) 5
adult (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
clinical trials (4) 4
patients (4) 4
pneumonia (4) 4
therapy (4) 4
abridged index medicus (3) 3
aged (3) 3
analysis (3) 3
aspergillosis (3) 3
bacterial pneumonia (3) 3
catheter-related infections (3) 3
chronic lymphocytic-leukemia (3) 3
conferences and conventions (3) 3
conferences, meetings and seminars (3) 3
cytarabine - administration & dosage (3) 3
disease control (3) 3
drug therapy (3) 3
female (3) 3
fluconazole (3) 3
fungal infections (3) 3
guidelines (3) 3
hematopoietic stem cells (3) 3
immunosuppressive agents (3) 3
immunotherapy (3) 3
infections (3) 3
internal medicine (3) 3
lymphomas (3) 3
male (3) 3
medicine, general & internal (3) 3
mycoses - drug therapy (3) 3
neutropenia (3) 3
posaconazole (3) 3
prospective studies (3) 3
stem cells (3) 3
stem-cell transplantation (3) 3
trade and professional associations (3) 3
transplants & implants (3) 3
acute lymphoblastic-leukemia (2) 2
adolescent (2) 2
antifungal agents (2) 2
antifungal prophylaxis (2) 2
antimicrobial treatment (2) 2
antiparasitic agents (2) 2
biofilm (2) 2
blood (2) 2
bone-marrow-transplantation (2) 2
chicken pox (2) 2
combined modality therapy (2) 2
cytomegalovirus (2) 2
diagnosis (2) 2
double-blind (2) 2
drugs (2) 2
echinocandins (2) 2
epidemiology (2) 2
febrile neutropenia (2) 2
fever (2) 2
fever - drug therapy (2) 2
fungal-infections (2) 2
health risks (2) 2
hematology, oncology and palliative medicine (2) 2
hematopoietic stem cell transplantation (2) 2
hematopoietic stem cell transplantation - methods (2) 2
hepatitis (2) 2
high-risk patients (2) 2
infection (2) 2
infection prophylaxis (2) 2
influenza (2) 2
influenzae type-b (2) 2
intensive-care-unit (2) 2
invasive fungal infection (2) 2
invasive pulmonary aspergillosis (2) 2
itraconazole (2) 2
liposomal (2) 2
lymphoma (2) 2
lymphoma, mantle-cell - drug therapy (2) 2
measles (2) 2
medical examination (2) 2
medical treatment (2) 2
microbiology (2) 2
mycoses - epidemiology (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10044, pp. 565 - 575
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 381, Issue 9873, pp. 1203 - 1210
Summary Background Rituximab plus chemotherapy, most often CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone), is the first-line standard of... 
Internal Medicine | SURVIVAL | MAINTENANCE | MEDICINE, GENERAL & INTERNAL | II MULTICENTER | B-CELL | ADVANCED FOLLICULAR LYMPHOMA | CYCLOPHOSPHAMIDE | VINCRISTINE | NON-HODGKINS-LYMPHOMA | COMBINATION | CHEMOTHERAPY | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Nitrogen Mustard Compounds - administration & dosage | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cyclophosphamide - adverse effects | Vincristine - administration & dosage | Adult | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Prednisone - adverse effects | Lymphoma, Mantle-Cell - drug therapy | Rituximab | Treatment Outcome | Nitrogen Mustard Compounds - adverse effects | Disease-Free Survival | Bendamustine Hydrochloride | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - adverse effects | Aged | Infusions, Intravenous | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Usage | Chemotherapy | Bendamustine | Patient outcomes | Lymphomas | Research | Drug therapy | Comparative analysis | Cancer | Antimitotic agents | Care and treatment | Antineoplastic agents | Analysis | Bone marrow | Hematology
Journal Article
Journal Article
LANCET INFECTIOUS DISEASES, ISSN 1473-3099, 12/2019, Volume 19, Issue 12, pp. E405 - E421
Mucormycosis is a difficult to diagnose rare disease with high morbidity and mortality. Diagnosis is often delayed, and disease tends to progress rapidly.... 
REAL-TIME PCR | INFECTIOUS DISEASES | HIGH-RISK PATIENTS | ORGAN TRANSPLANT RECIPIENTS | PULMONARY MUCORMYCOSIS | 7-YEAR RETROSPECTIVE ANALYSIS | REVERSED HALO SIGN | RENAL MUCORMYCOSIS | LIPOSOMAL AMPHOTERICIN-B | INVASIVE MOLD INFECTIONS | FUNGAL-INFECTIONS | Practice guidelines (Medicine) | Mucormycosis | Care and treatment | Diagnosis
Journal Article
Haematologica, ISSN 0390-6078, 02/2016, Volume 101, Issue 2, pp. 115 - 208
Journal Article
Haematologica, ISSN 0390-6078, 01/2009, Volume 94, Issue 1, pp. 113 - 122
Journal Article
Annals of Hematology, ISSN 0939-5555, 2/2018, Volume 97, Issue 2, pp. 197 - 207
Journal Article
Annals of Hematology, ISSN 0939-5555, 1/2014, Volume 93, Issue 1, pp. 13 - 32
The Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO) here presents its updated recommendations for the... 
Hematologic malignancies | Invasive candidiasis | Medicine & Public Health | Hematology | Antifungal agents | Aspergillosis | Mycoses | Oncology | PERSISTENT FEBRILE NEUTROPENIA | NERVOUS-SYSTEM ASPERGILLOSIS | CHRONIC DISSEMINATED CANDIDIASIS | ACUTE MYELOID-LEUKEMIA | CATHETER-RELATED INFECTIONS | LIPOSOMAL AMPHOTERICIN-B | TRICHOSPORON-ASAHII INFECTION | CLINICAL-PRACTICE GUIDELINES | HIGH-DOSE FLUCONAZOLE | SCEDOSPORIUM-PROLIFICANS INFECTION | HEMATOLOGY | Triazoles - administration & dosage | Triazoles - adverse effects | Antifungal Agents - adverse effects | Humans | Salvage Therapy | Catheter-Related Infections - prevention & control | Antifungal Agents - therapeutic use | Echinocandins - administration & dosage | Neoplasms - complications | Invasive Pulmonary Aspergillosis - etiology | Fungemia - drug therapy | Immunotherapy | Candidiasis, Invasive - drug therapy | Amphotericin B - administration & dosage | Mycoses - therapy | Drug Therapy, Combination | Candidiasis, Invasive - etiology | Triazoles - therapeutic use | Invasive Pulmonary Aspergillosis - drug therapy | Mycoses - surgery | Clinical Trials as Topic | Combined Modality Therapy | Chemotherapy-Induced Febrile Neutropenia - complications | Fungemia - prevention & control | Catheter-Related Infections - drug therapy | Amphotericin B - adverse effects | Echinocandins - adverse effects | Invasive Pulmonary Aspergillosis - surgery | Mycoses - drug therapy | Echinocandins - therapeutic use | Immunocompromised Host | Amphotericin B - therapeutic use | Drug Monitoring | Antifungal Agents - administration & dosage | Mycoses - etiology | Cancer patients | Care and treatment | Chemotherapy | Mortality | Clinical trials | Health aspects | Cancer | Original
Journal Article